TY - JOUR
T1 - Oxidized high-density lipoprotein associates with atrial fibrillation
AU - Pagonas, Nikolaos
AU - Mueller, Rhea
AU - Weiland, Linda
AU - Jaensch, Monique
AU - Dammermann, Werner
AU - Seibert, Felix S.
AU - Hillmeister, Philipp
AU - Buschmann, Ivo
AU - Christ, Martin
AU - Ritter, Oliver
AU - Westhoff, Timm H.
AU - Sasko, Benjamin
AU - Kelesidis, Theodoros
N1 - Publisher Copyright:
© 2023 Heart Rhythm Society
PY - 2024/4
Y1 - 2024/4
N2 - Background: Atrial fibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with increased morbidity and mortality. Recent data suggest a link between inflammation, oxidative stress, and AF, although the underlying mechanisms are not fully understood. Because oxidized lipoproteins cause structural damage and electrophysiologic changes in cardiomyocytes, it is feasible that the transformation of atheroprotective high-density lipoprotein (HDL) into dysfunctional HDL contributes to the development of AF. Objective: The purpose of this study was to determine whether a reduced antioxidant function of HDL is associated with the presence of AF. Methods: In this multicenter cross-sectional cohort study, we assessed HDL function in sera of 1206 participants. Patients were divided into groups according to the presence of AF (n = 233) or no AF (n = 973). A validated cell-free biochemical assay was used to determine reduced HDL antioxidant function as assessed by increased normalized HDL lipid peroxide content (nHDLox). Results: Participants with AF had a 9% higher mean relative nHDLox compared to persons without AF (P = .025). nHDLox was strongly associated with AF in all models of logistic regression, including the analysis adjusted for age, sex, and risk factors for AF (all P ≤.01). Conclusion: Reduced antioxidant HDL function is associated with the presence of AF, which supports growing evidence that impaired lipoprotein function is linked to electrophysiological changes in cardiomyocytes. nHDLox is one of several contributors to the initiation and perpetuation of AF.
AB - Background: Atrial fibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with increased morbidity and mortality. Recent data suggest a link between inflammation, oxidative stress, and AF, although the underlying mechanisms are not fully understood. Because oxidized lipoproteins cause structural damage and electrophysiologic changes in cardiomyocytes, it is feasible that the transformation of atheroprotective high-density lipoprotein (HDL) into dysfunctional HDL contributes to the development of AF. Objective: The purpose of this study was to determine whether a reduced antioxidant function of HDL is associated with the presence of AF. Methods: In this multicenter cross-sectional cohort study, we assessed HDL function in sera of 1206 participants. Patients were divided into groups according to the presence of AF (n = 233) or no AF (n = 973). A validated cell-free biochemical assay was used to determine reduced HDL antioxidant function as assessed by increased normalized HDL lipid peroxide content (nHDLox). Results: Participants with AF had a 9% higher mean relative nHDLox compared to persons without AF (P = .025). nHDLox was strongly associated with AF in all models of logistic regression, including the analysis adjusted for age, sex, and risk factors for AF (all P ≤.01). Conclusion: Reduced antioxidant HDL function is associated with the presence of AF, which supports growing evidence that impaired lipoprotein function is linked to electrophysiological changes in cardiomyocytes. nHDLox is one of several contributors to the initiation and perpetuation of AF.
KW - Atrial fibrillation
KW - High-density lipoprotein function
KW - Inflammation
KW - Lipid peroxidation
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85183199715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183199715&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2023.11.024
DO - 10.1016/j.hrthm.2023.11.024
M3 - Article
C2 - 38040404
AN - SCOPUS:85183199715
SN - 1547-5271
VL - 21
SP - 362
EP - 369
JO - Heart Rhythm
JF - Heart Rhythm
IS - 4
ER -